Related Experiment Video
Updated: Jun 27, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse
Dongyun Zhang1, Jingxia Li, Jimin Gao
1Nelson Institute of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.
Abstract:
Arsenic is a well-documented human carcinogen associated with skin carcinogenesis. Our previous work reveals that arsenite exposure is able to induce cell transformation in mouse epidermal cell JB6 Cl41 through the activation of ERK, rather than JNK pathway. Our current studies further evaluate downstream pathway in low dose arsenite-induced cell transformation in JB6 Cl41 cells. Our results showed that treatment of cells with low dose arsenite induced activation of c-Jun/AP-1 pathway, and ectopic expression of dominant negative mutant of c-Jun (TAM67) blocked arsenite-induced transformation. Furthermore, our data indicated that cyclin D1 was an important downstream molecule involved in c-Jun/AP-1-mediated cell transformation upon low dose arsenite exposure, because inhibition of cyclin D1 expression by its specific siRNA in the JB6 Cl41 cells resulted in impairment of anchorage-independent growth of cells induced by low dose arsenite. Collectively, our results demonstrate that c-Jun/AP-1-mediated cyclin D1 expression is at least one of the key events implicated in cell transformation upon low dose arsenite exposure.
Insights
Low dose arsenite exposure triggers skin cell transformation by activating the c-Jun/AP-1 pathway. This process involves cyclin D1, a key molecule in arsenite-induced carcinogenesis.
Area of Science:
- Environmental Toxicology
- Molecular Carcinogenesis
- Dermatology
Background:
- Arsenic is a known human carcinogen linked to skin cancer.
- Previous research indicated arsenite induces cell transformation via ERK, not JNK pathways.
Purpose of the Study:
- To investigate downstream pathways in low-dose arsenite-induced cell transformation.
- To identify key molecular events in arsenite-mediated skin carcinogenesis.
Main Methods:
- Utilized mouse epidermal JB6 Cl41 cells.
- Assessed activation of c-Jun/AP-1 pathway.
- Employed dominant-negative c-Jun (TAM67) and cyclin D1 siRNA.
Main Results:
- Low-dose arsenite activated the c-Jun/AP-1 pathway.
- TAM67 expression blocked arsenite-induced transformation.
- Cyclin D1 inhibition impaired arsenite-induced anchorage-independent growth.
Conclusions:
- c-Jun/AP-1 pathway activation is crucial for arsenite-induced cell transformation.
- Cyclin D1 is a key downstream mediator in this process.
- These findings elucidate mechanisms of skin carcinogenesis by low-dose arsenic.
Related Concept Videos
MAPK Signaling Cascades
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
Anaphase Promoting Complex
Positive Regulator Molecules
Positive Regulator Molecules
